SCHEMBL21498090

SCHEMBL21498090

CC(S)N1CCNC(c2ccccc2)C1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ PDE10A Q9Y233 1/20 0.39
▸ GSK3B P49841 2/20 0.38
▸ RPS6KB1 P23443 1/20 0.35
▸ SLC6A2 P23975 1/20 0.35
▸ ADRA1A P35348 1/20 0.35
▸ HTR2B P41595 1/20 0.35
▸ SLC6A3 Q01959 1/20 0.35
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ PRKCQ Q04759 3/20 0.34
▸ PRKCD Q05655 1/20 0.34
▸ CYP2D6 P10635 1/20 0.33
▸ PRCP P42785 1/20 0.33
▸ KCNH2 Q12809 1/20 0.32
▸ HRH3 Q9Y5N1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10349652 0.87 PDE10A (0.40) KDM4EALDH1A1PDE10AGSK3BRPS6KB1
Hydrochloric Acid SCHEMBL10382640 0.86 GSK3B (0.40) KDM4EALDH1A1PDE10AGSK3BRPS6KB1
SCHEMBL19629766 0.79 PDE10A (0.38) KDM4EPDE10AGSK3BMEN1KMT2A
SCHEMBL11707727 0.79 OPRD1 (0.37) KDM4EALDH1A1PDE10AGSK3BRPS6KB1
SCHEMBL2908444 0.75 PDE10A (0.45) KDM4EALDH1A1PDE10AGSK3BRPS6KB1
SCHEMBL90572 0.75 PDE10A (0.45) KDM4EALDH1A1PDE10AGSK3BRPS6KB1
SCHEMBL2910280 0.75 PDE10A (0.45) KDM4EALDH1A1PDE10AGSK3BRPS6KB1
SCHEMBL21831322 0.74 HRH3 (0.47) KDM4ESLC6A2ADRA1AHTR2BSLC6A3
Hydrochloric Acid SCHEMBL27510131 0.73 GSK3B (0.45) KDM4EALDH1A1PDE10AGSK3BRPS6KB1
Hydrochloric Acid SCHEMBL10626673 0.73 GSK3B (0.45) KDM4EALDH1A1PDE10AGSK3BRPS6KB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10450318-B2 CXCR4 receptor antagonists BRISTOL-MYERS SQUIBB COMPANY (US) 2019-10-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10450318-B2 CXCR4 receptor antagonists CXCR4, CXCR1, CXCR2 KDM4E 4172/4885ALDH1A1 856/4885PDE10A 583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback